Want to save the NHS? It’s all about Britain’s medical tech

Published on: 12 Sep 2018

Owlstone Medical® has been highlighted in the Evening Standard for our pioneering work developing Breath Biopsy®. The article looks at the exciting movements in the medical technology sector and has identified the potential benefits our technology could deliver to the healthcare sector in the future. Breath Biopsy has great potential as a diagonistic for non-invasive early detection of dieases, like cancer.

Article extract:

“Britain is in the vanguard of the ‘medtech’ revolution, with more than 500,000 registered medical technology companies and revenues of £21 billion last year. Many of the firms turning the industry on its head are in the so-called Cambridge Corridor, such as Owlstone Medical”

Read the article

Breath Biopsy®

If you want to learn more about how Owlstone Medical’s Breath Sampling and Analysis technology and Services could be utilized in early detection and precision medicine, why not download our free ebook: Breath Biopsy: The Complete Guide?

Breath Biopsy Complete Guide

By investing in Owlstone Medical you can help make this happen sooner.

We are on a mission to save 100,000 lives. By investing in Owlstone Medical you can support our research and help make this happen sooner.

Discuss investment opportunities